Advertising exemption: Metamucil

Published in the Commonwealth of Australia Gazette, 1 May 2002

THERAPEUTIC GOODS ACT 1989

THERAPEUTIC GOODS REGULATIONS

I, Sharyn McGregor, Acting Director, Chemicals & Non-prescription Medicines Branch, Therapeutic Goods Administration and delegate of the Secretary to the Department of Health and Ageing for the purposes of Regulation 7C (1) of the Therapeutic Goods Regulations, give notice that the restricted representation described in paragraph (a) below, has been approved for use in advertisements directed to consumers, for the products listed in paragraph (b):

1. A representation to the effect that goods described in paragraph (b) below are:
   • "Diets low in saturated fat and cholesterol that include 7 grams of soluble fibre from psyllium husk, as in Metamucil, may lower cholesterol levels. Reductions in cholesterol may contribute to reducing the risk of heart disease"
2. ORIGINAL TEXTURE METAMUCIL Orange flavour AUST R 10184
   ORIGINAL TEXTURE METAMUCIL Regular flavour AUST R 10186
   METAMUCIL SMOOTH TEXTURE orange flavour AUST R 47537
   METAMUCIL SMOOTH TEXTURE orange flavour AUST R 47539

Dated this    day of April 2002

SHARYN McGREGOR
Delegate of the Secretary to the Department of Health and Ageing